Stay updated with breaking news from Staffan Stro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Message from the CEO Our Phase-III study, the largest of its kind ever conducted, is progressing across 88 hospitals in ten countries. We have now recruited 85% of the patients , and with the current...
At the Extraordinary General Meeting of Infant Bacterial Therapeutics AB on June 9, 2023, it was resolved to approve the Board of Directors’ resolution from May 16, 2023 to increase the... | June 9, 2023
At the Annual General Meeting of Infant Bacterial Therapeutics AB on May 8, 2023, among other things, the following was resolved: to adopt the income statement and balance sheet and the consolidated... | May 8, 2023
At the Annual General Meeting of Infant Bacterial Therapeutics AB (publ) on May 8, 2023, among other things, the following was resolved: to adopt the...
Message from the CEO The speed of recruitment of preterm infants into our large phase 3 study significantly increased in the final three months of...